Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 433

Research article2014

PROSPECTS OF TETRAPEPTIDE APPLICATION IN TREATMENT OF CHRONIC BRONCHITIS: MOLECULAR MECHANISMS

Introduction. Chronic bronchitis is one of the socially significant diseases. Accordingly, a search of the new more effective and safe bronchoprotective drugs is the one of aims of molecular medicine. The aim of the study. The goal of our research was the inve…

Details ↗
Research article2014

GALECTIN-1 INDUCES MITOCHONDRIAL APOPTOTIC PATHWAY IN CD4+ T-CELLS

Introduction. Galectin-1 binds to cell surface glycoprotein and participates in cooperation of immune cells. It is supposed that the CD4+- lymphocytes can be target for immunosuppressive activity of galectin-1. However, there is no sufficient information about…

Details ↗
Research article2014

THE ROLE OF VIOLATIONS IN THE CYTOKINES SYTEM OF THE INTERLEUKIN 12 FAMILY AND THEIR RECEPTORS IN IMMUNOPATHOGENESIS OF TUBERCULOSIS

Introduction. Disorders in anti-TB immunity may be formed at the stage of interaction between antigen-presenting cells and T-lymphocytes by means of cytokines and their receptors. The key cytokines of T-lymphocyte activation are interleukins (IL) of the IL12 f…

Details ↗
Research article2014

COMPARATIVE BIOCOMPATIBILITY OF NONWOVEN POLYMER SCAFFOLDS OBTAINED BY ELECTROSPINNING AND THEIR USE FOR DEVELOPMENT OF 3D DERMAL EQUIVALENTS

Introduction. One of the most prospective approaches in therapy of deep skin burns is the development of artificial dermal equivalents with a potential to provide efficient scaffolding for dermis reconstruction and re-epithelisation. The choice of material for…

Details ↗
Research article2014

SEVERAL GENETIC FEATURES OF HUMAN METASTATIC CUTANEOUS MELANOMA

Introduction. The prevalence of human cutaneous melanoma (CM) in the world is constantly rising. Diagnostics and treatment of CM at the early stages allows to increase the 5-year patient survival up to 90%. This problem can be solved with personalized therapy …

Details ↗
Research article2014

THE PHOSPHORYLATED AKT1 KINASE, VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS RECEPTORS: INTRATUMORAL CONTENT AND PROGNOSTIC SIGNIFICANCE IN BREAST CANCER PATIENTS

Introduction. PI3K/Akt signaling pathway is an important intracellular regulatory mechanism controlling cues of growth factors stimuli, apoptosis, proliferation, and cell motility. Deregulation of activity/expression of PI3K/Akt signaling pathway proteins dete…

Details ↗
Research article2014

MOLECULAR GENETIC MARKERS OF NON-SMALL CELL LUNG CANCER

Lung cancer is one of the most common oncologic diseases in the world and the most frequent cause of the death from malignant neoplasms. Last decade’s studies revealed significant number of molecular events leading to the onset and development of non-small cel…

Details ↗
Research article2014

INTERLEUKIN 16 IN THE SERUM BONE

Introduction. Progress in the treatment of cancer and bone tumors including, is associated with a significant breakthrough in molecular biology, immunology, understanding the causes of the emergence of the tumor cell, patterns of the development and course of …

Details ↗
Research article2014

RESEARCH OF ANTINEOPLASTIC ACTIVITY OF CHIMERIC PEPTIDE P16_ANTP IN VIVO

Introduction. P16INK4a protein plays one of the key role in processes of cell proliferation, its inactivation is noted in a number of tumors of various localization. Restoration of the p16INK4a function in neoplastic cells may promote braking of division of tu…

Details ↗
Research article2014

SEARCH FOR ANTAGONISTS OF NR3C4 RECEPTOR

Introduction. One of the main types of a hormonal therapy in the treatment of the cancer of the prostate gland is the antagonists of the NR3C4 (nuclear receptor subfamily 3, group C, member 4) receptor. It blocks binding of man’s hormones with receptors site, …

Details ↗

Article search and quick navigation

Navigation